177 related articles for article (PubMed ID: 37083973)
21. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
Li J; Tang X; Luo X; Liu L; Li D; Yang L
Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
[TBL] [Abstract][Full Text] [Related]
22. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
[TBL] [Abstract][Full Text] [Related]
23. Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis.
Guha A; Goda JS; Dasgupta A; Mahajan A; Halder S; Gawde J; Talole S
Front Oncol; 2022; 12():884173. PubMed ID: 36263203
[TBL] [Abstract][Full Text] [Related]
24. Primary Central Nervous System Lymphoma: Clinical Evaluation of Automated Segmentation on Multiparametric MRI Using Deep Learning.
Pennig L; Hoyer UCI; Goertz L; Shahzad R; Persigehl T; Thiele F; Perkuhn M; Ruge MI; Kabbasch C; Borggrefe J; Caldeira L; Laukamp KR
J Magn Reson Imaging; 2021 Jan; 53(1):259-268. PubMed ID: 32662130
[TBL] [Abstract][Full Text] [Related]
25. A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study.
Wei L; Gao Y; Prochazka KT; Liu R; Wang L; Liu B; He Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Deutsch AJ; Zhan H; Lai J; Kim SJ; You H
J Neurooncol; 2023 Jun; 163(2):301-311. PubMed ID: 37231231
[TBL] [Abstract][Full Text] [Related]
26. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
[TBL] [Abstract][Full Text] [Related]
27. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
28. What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Inoue A; Matsumoto S; Ohnishi T; Miyazaki Y; Kinnami S; Kanno K; Honda T; Kurata M; Taniwaki M; Kusakabe K; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Kunieda T
World Neurosurg; 2023 Apr; 172():e517-e523. PubMed ID: 36690204
[TBL] [Abstract][Full Text] [Related]
29. Machine Learning and Deep Learning CT-Based Models for Predicting the Primary Central Nervous System Lymphoma and Glioma Types: A Multicenter Retrospective Study.
Lu G; Zhang Y; Wang W; Miao L; Mou W
Front Neurol; 2022; 13():905227. PubMed ID: 36110392
[TBL] [Abstract][Full Text] [Related]
30. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
32. An integrative non-invasive malignant brain tumors classification and Ki-67 labeling index prediction pipeline with radiomics approach.
Zhang L; Liu X; Xu X; Liu W; Jia Y; Chen W; Fu X; Li Q; Sun X; Zhang Y; Shu S; Zhang X; Xiang R; Chen H; Sun P; Geng D; Yu Z; Liu J; Wang J
Eur J Radiol; 2023 Jan; 158():110639. PubMed ID: 36463703
[TBL] [Abstract][Full Text] [Related]
33. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
[TBL] [Abstract][Full Text] [Related]
34. Study on primary central nervous system lymphoma in pediatric patients.
Li X; Gong J
Childs Nerv Syst; 2023 Aug; 39(8):2037-2043. PubMed ID: 37401975
[TBL] [Abstract][Full Text] [Related]
35. Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks.
McAvoy M; Prieto PC; Kaczmarzyk JR; Fernández IS; McNulty J; Smith T; Yu KH; Gormley WB; Arnaout O
Sci Rep; 2021 Jul; 11(1):15219. PubMed ID: 34312463
[TBL] [Abstract][Full Text] [Related]
36. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
[TBL] [Abstract][Full Text] [Related]
37. [Formula: see text]: deep learning-based radiomics for the time-to-event outcome prediction in lung cancer.
Afshar P; Mohammadi A; Tyrrell PN; Cheung P; Sigiuk A; Plataniotis KN; Nguyen ET; Oikonomou A
Sci Rep; 2020 Jul; 10(1):12366. PubMed ID: 32703973
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
[TBL] [Abstract][Full Text] [Related]
39. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
[TBL] [Abstract][Full Text] [Related]
40. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
